NCT03339622View on ClinicalTrials.gov

Safety and Efficacy of Smoked Cannabis for Improving Quality of Life in Advanced Cancer Patients

PHASE3TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 29, 2018

Primary Completion Date

December 17, 2018

Study Completion Date

February 8, 2019

Conditions
CancerChronic Pain Due to Malignancy (Finding)
Interventions
COMBINATION_PRODUCT

PPP001

1 pellet smoked three times a day with titanium pipe (280 mg dried cannabis pellet - 9% THC / 2% CBD per pellet)

COMBINATION_PRODUCT

placebo

1 pellet smoked three times a day with titanium pipe (280 mg dried cannabis pellet - 0% THC / 0.6% CBD per pellet)

Trial Locations (1)

H2L 3K9

Sante Cannabis, Montreal

Sponsors

Lead Sponsor

Tetra Bio-Pharma
All Listed Sponsors
lead

Tetra Bio-Pharma

INDUSTRY